ロード中...
Systemic administration of β(2)-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses
1. β(2)-Adrenoceptor agonists provide a potential therapy for muscle wasting and weakness, but their use may be limited by adverse effects on the heart, mediated in part, by β(1)-adrenoceptor activation. 2. Two β(2)-agonists, formoterol and salmeterol, are approved for treating asthma and have an ex...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2006
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1751341/ https://ncbi.nlm.nih.gov/pubmed/16432501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0706669 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|